Daxor Corp
NASDAQ:DXR

Watchlist Manager
Daxor Corp Logo
Daxor Corp
NASDAQ:DXR
Watchlist
Price: 9.02 USD -7.01% Market Closed
Market Cap: $52.6m

Multiples-Based Value

The Multiples-Based Value of one DXR stock under the Base Case scenario is 0.02 USD. Compared to the current market price of 9.02 USD, Daxor Corp is Overvalued by 100%.

Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

DXR Multiples-Based Value
Base Case
0.02 USD
Overvaluation 100%
Multiples-Based Value
Price $9.02
Worst Case
Base Case
Best Case

Multiples Across Competitors

DXR Competitors Multiples
Daxor Corp Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Daxor Corp
NASDAQ:DXR
52.6m USD 1 969.5 5.7 -46.8 -46.8
US
Abbott Laboratories
NYSE:ABT
177.7B USD 4 27.2 15.6 21.4
US
Intuitive Surgical Inc
NASDAQ:ISRG
160.7B USD 16 56.3 42.6 52.3
US
Stryker Corp
NYSE:SYK
127.1B USD 5.1 39.2 20 24.2
IE
Medtronic PLC
NYSE:MDT
110.7B USD 3.1 24 13.3 19.3
US
Boston Scientific Corp
NYSE:BSX
92.8B USD 4.6 32 19 25.5
US
Edwards Lifesciences Corp
NYSE:EW
47.1B USD 7.8 43.9 24.1 26.4
DE
Siemens Healthineers AG
XETRA:SHL
40.6B EUR 1.8 19.3 10.9 15.3
US
IDEXX Laboratories Inc
NASDAQ:IDXX
46B USD 10.7 43.5 30.8 34.1
US
Becton Dickinson and Co
NYSE:BDX
44.2B USD 2 25.2 10 16.8
US
Resmed Inc
NYSE:RMD
32.8B USD 6.1 22.1 15.5 17.2
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
Daxor Corp
NASDAQ:DXR
Average EV/EBITDA: 20.2
Negative Multiple: -46.8
N/A N/A
US
Abbott Laboratories
NYSE:ABT
15.6
11%
1.4
US
Intuitive Surgical Inc
NASDAQ:ISRG
42.6
23%
1.9
US
Stryker Corp
NYSE:SYK
20
12%
1.7
IE
Medtronic PLC
NYSE:MDT
13.3
8%
1.7
US
Boston Scientific Corp
NYSE:BSX
19
18%
1.1
US
Edwards Lifesciences Corp
NYSE:EW
24.1
14%
1.7
DE
Siemens Healthineers AG
XETRA:SHL
10.9
10%
1.1
US
IDEXX Laboratories Inc
NASDAQ:IDXX
30.8
11%
2.8
US
Becton Dickinson and Co
NYSE:BDX
10
1%
10
US
Resmed Inc
NYSE:RMD
15.5
11%
1.4
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
Daxor Corp
NASDAQ:DXR
Average EV/EBIT: 25.3
Negative Multiple: -46.8
N/A N/A
US
Abbott Laboratories
NYSE:ABT
21.4
18%
1.2
US
Intuitive Surgical Inc
NASDAQ:ISRG
52.3
25%
2.1
US
Stryker Corp
NYSE:SYK
24.2
16%
1.5
IE
Medtronic PLC
NYSE:MDT
19.3
17%
1.1
US
Boston Scientific Corp
NYSE:BSX
25.5
25%
1
US
Edwards Lifesciences Corp
NYSE:EW
26.4
15%
1.8
DE
Siemens Healthineers AG
XETRA:SHL
15.3
15%
1
US
IDEXX Laboratories Inc
NASDAQ:IDXX
34.1
12%
2.8
US
Becton Dickinson and Co
NYSE:BDX
16.8
15%
1.1
US
Resmed Inc
NYSE:RMD
17.2
12%
1.4
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett